skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8799

Mortality following operations for lower extremity peripheral arterial disease

Original Research

(2029) Views  (576) Full article downloads

Authors: Tracie C Collins, David Nelson, Jasjit S Ahluwalia

Published Date May 2010 Volume 2010:6 Pages 287 - 296
DOI: http://dx.doi.org/10.2147/VHRM.S8899

Tracie C Collins1,2, David Nelson3, Jasjit S Ahluwalia1,2

1Department of Medicine, Division of General Internal Medicine, University of Minnesota Minneapolis, MN, USA; 2Center for Health Equity, University of Minnesota Medical School, Minneapolis, MN, USA; 3Minneapolis VA Medical Center, Center for Chronic Disease Outcomes Research, University of Minnesota, Minneapolis, MN, USA

Background: We sought to identify risk factors associated with mortality following surgery for peripheral arterial disease (PAD).

Methods: We evaluated the association between levels of control of atherosclerotic risk factors and time to mortality following either lower extremity bypass surgery or lower extremity amputation using Cox proportional hazards regression.

Results: Among 796 patients with PAD (defined by an ankle-brachial index [ABI] < 0.9), 230 (28.9%) underwent an operation for PAD (136, lower-extremity bypasses; 111, lower-extremity amputations). Participants were followed for up to six years after their diagnosis of PAD. A total of 107 (46.5% of the 230) died during the period of follow-up. Factors associated with mortality following lower extremity bypass surgery included age 70 years and older hazard ratio [HR] 1.88; 95% confidence interval [CI]: 1.01–3.51) and of African American race (HR 1.94; 95% CI: 1.04–3.62). Renal insufficiency was significantly associated with mortality following lower extremity amputation (HR 2.19; 95% CI: 1.16–4.13).

Conclusion: Our data provide information on preoperative risk variables to consider when assessing long-term mortality in persons with PAD who are undergoing surgery for PAD.

Keywords: risk factors, mortality, bypass surgery, ankle-brachial index








Readers of this article also read:

Does plasmin have anticoagulant activity?
Recent achievements in the management of Raynaud’s phenomenon
Feasibility and effectiveness of a disease and care management model in the primary health care system for patients with heart failure and diabetes (Project Leonardo)
Should we screen for masked hypertension in patient with vascular disease?
Effect of lipopenic and hypotensive treatment on homocysteine levels in type 2 diabetics
Do we need more than just powerful blood pressure reductions? New paradigms in end-organ protection
Management of acute attacks of hereditary angioedema: potential role of icatibant
Predictors of poor blood pressure control assessed by 24 hour monitoring in patients with type B acute aortic dissection
Doppler ultrasound venous mapping of the lower limbs
Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University